4,500
Participants
Start Date
September 1, 2021
Primary Completion Date
June 30, 2024
Study Completion Date
September 30, 2024
Genetic Screening
Blood samples will be collected from clinically diagnosed or suspected FTD patients and will be analysed for a broad range of pathogenic variants in genes associated with FTD.
CHU de Liege, Liège
AZ Damiaan, Ostend
AGZ of Charite Universitätsmedizin Berlin, Berlin
Mediterraneo Hospital, Athens
University Hospital Rostock, Rostock
University Medical Center Hamburg Eppendorf, Hamburg
Asklepios Klinik Nord - Ochsenzoll, Hamburg
University of Lübeck, Lübeck
Universitary Hospital La Princesa, Madrid
Hospital Clinico San Carlos, Madrid
Hospital Universitario 12 de Octubre, Madrid
Clinica Universidad de Navarra, Pamplona
Koç University Hospital, Istanbul
Istanbul University, Istanbul
Bezmialem Vakif University, Istanbul
Izmir Economy University Medikalpark Hospital, Izmir
Gertrudis Klinik, Leun
Marqués de Valdecilla University Hospital, Santander
Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia
Azienda Ospedaliero-Universitaria di Parma, Parma
University of Ioannina, Ioannina
University Hospital Cologne, Cologne
RWTH Aachen University, Aachen
Hochtaunus-Kliniken gGmbH, Bad Homburg
Hanau Hospital, Hanau
Università degli studi Gabriele D'Annunzio Chieti-Pescara, Chieti
Azienda Ospedaliera Universitaria Federico II di Napoli, Napoli
University Hospital Dresden, Dresden
Hospital Garcia de Orta, Almada
Unidade Psiquiatrica Privada de Coimbra, Coimbra
Hospital da Senhora da Oliveira Guimaraes, Guimarães
Hospital Beatriz Ângelo, Loures
Hospital Pedro Hispano, Matosinhos Municipality
CNS - campus neurológico Torres Vedras, Torres Vedras
Hospital Universitari vall D´hebron, Barcelona
Baskent University, Ankara
Hacettepe University, Ankara
CENTOGENE GmbH Rostock
INDUSTRY